Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value … X Ou, X Zhou, Q Shi, X Xing, Y Yang, T Xu, C Shen, X Wang, X He, ... Oncotarget 6 (35), 38381, 2015 | 100 | 2015 |
Neuroprotective role of δ-opioid receptors against mitochondrial respiratory chain injury M Zhu, M Li, X Tian, X Ou, C Zhu, J Guo Brain research 1252, 183-191, 2009 | 67 | 2009 |
Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study X Zhou, X Ou, T Xu, X Wang, C Shen, J Ding, C Hu International Journal of Radiation Oncology* Biology* Physics 90 (2), 261-269, 2014 | 63 | 2014 |
The impact of training sample size on deep learning-based organ auto-segmentation for head-and-neck patients Y Fang, J Wang, X Ou, H Ying, C Hu, Z Zhang, W Hu Physics in Medicine & Biology 66 (18), 185012, 2021 | 47 | 2021 |
The added value of 68Ga-FAPI PET/CT in patients with head and neck cancer of unknown primary with 18F-FDG–negative findings B Gu, X Xu, J Zhang, X Ou, Z Xia, Q Guan, S Hu, Z Yang, S Song Journal of Nuclear Medicine 63 (6), 875-881, 2022 | 44 | 2022 |
The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck … X Ou, Y Miao, X Wang, J Ding, X He, C Hu Radiation Oncology 12, 1-11, 2017 | 31 | 2017 |
Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation X Ou, C Shen, L Kong, X Wang, J Ding, Y Gao, T Xu, C Hu Oral oncology 48 (10), 1045-1050, 2012 | 29 | 2012 |
Mitochondrial ERK plays a key role in delta-opioid receptor neuroprotection against acute mitochondrial dysfunction M Zhu, M Li, F Yang, X Ou, Q Ren, H Gao, C Zhu, J Guo Neurochemistry international 59 (6), 739-748, 2011 | 29 | 2011 |
Automatic T staging using weakly supervised deep learning for nasopharyngeal carcinoma on MR images Q Yang, Y Guo, X Ou, J Wang, C Hu Journal of Magnetic Resonance Imaging 52 (4), 1074-1082, 2020 | 24 | 2020 |
Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy J Wang, Y Miao, X Ou, X Wang, X He, C Shen, H Ying, W Hu, C Hu Radiation Oncology 14, 1-7, 2019 | 24 | 2019 |
Cetuximab in combination with chemoradiotherapy in the treatment of recurrent and/or metastatic nasopharyngeal carcinoma T Xu, X Ou, C Shen, C Hu Anti-cancer drugs 27 (1), 66-70, 2016 | 24 | 2016 |
Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy Z Le, X Niu, Y Chen, X Ou, G Zhao, Q Liu, W Tu, C Hu, L Kong, Y Liu Oncotarget 8 (38), 63026, 2017 | 23 | 2017 |
The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT T Xu, C Shen, X Ou, X He, H Ying, C Hu Oncotarget 7 (15), 21013, 2016 | 23 | 2016 |
EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene Y Huang, X Wang, X Niu, X Wang, R Jiang, T Xu, Y Liu, L Liang, X Ou, ... Molecular carcinogenesis 56 (2), 447-463, 2017 | 20 | 2017 |
Quantitative metastatic lymph node regions on magnetic resonance imaging are superior to AJCC N classification for the prognosis of nasopharyngeal carcinoma X Zhou, X Ou, Y Yang, T Xu, C Shen, J Ding, C Hu Journal of oncology 2018 (1), 9172585, 2018 | 19 | 2018 |
LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy C Chu, X Niu, X Ou, C Hu OncoTargets and therapy, 5661-5677, 2019 | 16 | 2019 |
Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study Y Li, X Ou, C Hu Journal of Cancer 10 (3), 620, 2019 | 12 | 2019 |
Patterns of local failures and suggestions for reduction of clinical target volume for nasopharyngeal carcinoma patients without cervical lymph node metastasis Y Li, X Ou, C Shen, T Xu, W Li, C Hu OncoTargets and therapy, 2545-2555, 2018 | 12 | 2018 |
Interplay of tumor spread, volume and Epstein-Barr virus DNA in nasopharyngeal carcinoma: feasibility of an integrative risk stratification scheme X Zhou, Y Yang, X Ou, T Xu, C Shen, C Hu Journal of Cancer 9 (22), 4271, 2018 | 12 | 2018 |
Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A … X Ou, T Xu, X He, H Ying, C Hu Journal of Cancer 8 (14), 2836, 2017 | 12 | 2017 |